Raymond C Stevens's Net Worth
$33.6 Million
Who is Raymond C Stevens?
Raymond C Stevens has an estimated net worth of $33.6 Million. This is based on reported shares across multiple companies, which include DANAHER CORP /DE/, and Structure Therapeutics Inc..
SEC CIK
Raymond C Stevens's CIK is 0001698149
Past Insider Trading and Trends
2023 was Raymond C Stevens's most active year for acquiring shares with 10 total transactions. Raymond C Stevens's most active month to acquire stocks was the month of April. 2023 was Raymond C Stevens's most active year for disposing of shares, totalling 6 transactions. Raymond C Stevens's most active month to dispose stocks was the month of December. 2023 saw Raymond C Stevens paying a total of $981,863.92 for 1,610,592.378 shares, this is the most they've acquired in one year. In 2024 Raymond C Stevens cashed out on 890,000 shares for a total of $9,767,352.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DANAHER CORP /DE/ (DHR) Snapshot price: $266.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
| +3.61% | 390 |
—
|
—
| 11.21K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +4.97% | 430 |
—
|
—
| 9.08K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
$182.77 | -$1,370,827.46 | 8.39K |
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 29
| |||
Form 4
| +4.78% | 372 |
—
|
—
| 8.15K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
| +5.24% | 365 |
—
|
—
| 7.33K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 31
| |||
Form 4
| +9.86% | 575 |
—
|
—
| 6.41K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
| +15.96% | 690 |
—
|
—
| 5.01K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
| +36.74% | 870 |
—
|
—
| 3.24K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +662.20% | 990 |
—
|
—
| 1.14K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Structure Therapeutics Inc. (GPCR) Snapshot price: $36.9
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.32% | 150K |
$0.42 | $63,000.09 | 793.35K |
Jun 12
| |||
Form 4
| -46.31% | -555.00K |
—
|
—
| 643.35K |
Jun 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +12.66% | 134.68K |
—
|
—
| 1.2M |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||